Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
2009-9-30
pubmed:abstractText
Tumor DNA has been shown to be present both in circulating tumor cells in blood and as fragments in the plasma of metastatic cancer patients. The identification of ultra-rare tumor-specific mutations in blood would be the ultimate marker to measure efficacy of cancer therapy and/or early recurrence. Herein we present a method for detecting microinsertions/deletions/indels (MIDIs) at ultra-high analytical selectivity. MIDIs comprise about 15% of mutations.
pubmed:grant
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-11424181, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-11788724, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-12504766, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-14605056, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-14740499, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-15108273, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-15643612, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-16231326, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-16432518, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-16708764, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-16987840, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-17041903, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-17108085, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-17301845, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-17322893, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-17429853, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-17589521, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-17659080, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-17785543, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-18164685, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-18372921, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-18670422, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-2296286, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-2340178, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-2716852, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-7847369, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-8199598, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-8673103, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-9009845, http://linkedlifedata.com/resource/pubmed/commentcorrection/19789704-9814434
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1932-6203
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
4
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
e7220
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Analysis of cancer mutation signatures in blood by a novel ultra-sensitive assay: monitoring of therapy or recurrence in non-metastatic breast cancer.
pubmed:affiliation
Department of Molecular Genetics, City of Hope National Medical Center, Duarte, California, United States of America.
pubmed:publicationType
Journal Article, Research Support, N.I.H., Extramural